Effects of neuronal polypeptides on intestinal smooth muscle; a comparison with non-adrenergic, non-cholinergic nerve stimulation and ATP

Eur J Pharmacol. 1979 Mar 1;54(3):251-9. doi: 10.1016/0014-2999(79)90084-0.

Abstract

Substance P, somatostatin, enkephalin and vasoactive intestinal polypeptide (VIP) did not mimic the inhibitory responses to non-adrenergic, non-cholinergic nerve stimulation. Substance P (0.1-10 microgram/ml) always caused contraction, enkephalin (0.1-10 microgram/ml) and somatostatin (0.1 microgram/ml) were inactive, while VIP (0.1-1 microgram/ml) produced very slow relaxation, taking about 4 min to reach a maximum after a latency of about 60 sec. Low concentrations of neurotensin (1-10 ng/mg) caused contraction, but at higher concentrations (50-1000 ng/ml) it produced a biphasic response which consisted of an initial contraction followed by a slow relaxation. In high tone preparations, the slow relaxation did not mimic the nerve-mediated response, taking approximately 43 sec. to reach maximum, after a long latency of about 15 sec. In contrast, ATP (0.1-50 microgram/ml) mimicked closely the rapid responses to non-adrenergic, non-cholinergic nerve stimulation in all preparations, whether the tone was low, medium or high. The time for the inhibitory response to reach maximum was about 15 sec after a latency of approximately 1 sec. Indomethacin (3.4-34 microgram/ml) did not unmask any inhibitory responses to any of the peptides. It is concluded that ATP remains the most likely substance to be the inhibitory transmitter released from non-adrenergic, non-cholinergic nerves supplying the smooth muscle of the taenia coli.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Animals
  • Electric Stimulation
  • Enkephalins / pharmacology
  • Female
  • Guinea Pigs
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Intestines / drug effects
  • Intestines / innervation
  • Male
  • Muscle Contraction / drug effects*
  • Muscle, Smooth / drug effects*
  • Neurotensin / pharmacology
  • Peptides / pharmacology*
  • Somatostatin / pharmacology
  • Substance P / pharmacology
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Enkephalins
  • Peptides
  • Substance P
  • Vasoactive Intestinal Peptide
  • Neurotensin
  • Somatostatin
  • Adenosine Triphosphate
  • Indomethacin